Skip to main content

DBV Technologies S.A.

DBVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001613780

In the last 90 days, DBV Technologies S.A. insiders filed 0 open-market purchases and 1 sale; 78 institutions reported holding it in 13F filings for Q2 2026, worth $345.7M in total; Duquesne Family Office is the only superinvestor holding it.

Other share classesDBVTF

Q2 2026 vs. Q1 2026

How the institutions holding DBV Technologies S.A. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of DBVT: Q1 2026 compared with Q2 2026
MeasureQ1 2026Q2 2026Change
Holders7178+7
Shares21.2M21.5M+350.8K (+1.7%)
Value$433.6M$345.7M−$87.9M (−20.3%)

New holders (17)

Institutions that held DBV Technologies S.A. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to DBVT in Q2 2026
InstitutionSharesValue% of portfolio
Logos Global Management LP915,000$15.0M0.65%
Great Point Partners LLC156,906$2.57M0.61%
Diversify Advisory Services, LLC89,692$1.25M0.02%
Deutsche Bank AG59,240$971.5K0.00%
Citadel Advisors LLC22,782$373.6K0.00%
Point72 Asset Management, L.P.12,148$199.2K0.00%
Two Sigma Investments, LP11,630$190.7K0.00%
Geode Capital Management, LLC11,574$189.8K0.00%
State of Wyoming1,445$23.7K0.00%
Rockefeller Capital Management L.P.1,246$20.4K0.00%
Continuum Advisory, LLC400$6.56K0.00%
Bryn Mawr Trust Co276$4.53K0.00%
Nisa Investment Advisors, LLC200$3.28K0.00%
Silver Grove Financial Group, Inc.81$1.33K0.00%
Larson Financial Group LLC66$1.08K0.00%
National Bank of Canada23$3710.00%
Stone House Investment Management, LLC9$1480.00%

Sold out (10)

Institutions that held DBV Technologies S.A. at the end of Q1 2026 and filed for Q2 2026 without it.